Cargando…

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

PURPOSE: The relevance of the subfamily A members of ATP-binding cassette (ABCA) transporters as biomarkers of risk and response is emerging in different tumors, but their mechanisms of action have only been partially defined. In this work, we investigated their role in Ewing sarcoma (EWS), a pediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasello, Michela, Giudice, Anna Maria, Cristalli, Camilla, Manara, Maria Cristina, Mancarella, Caterina, Parra, Alessandro, Serra, Massimo, Magagnoli, Giovanna, Cidre-Aranaz, Florencia, Grünewald, Thomas G. P., Bini, Carla, Lollini, Pier-Luigi, Longhi, Alessandra, Donati, Davide Maria, Scotlandi, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747862/
https://www.ncbi.nlm.nih.gov/pubmed/36149602
http://dx.doi.org/10.1007/s13402-022-00713-5
_version_ 1784849698429861888
author Pasello, Michela
Giudice, Anna Maria
Cristalli, Camilla
Manara, Maria Cristina
Mancarella, Caterina
Parra, Alessandro
Serra, Massimo
Magagnoli, Giovanna
Cidre-Aranaz, Florencia
Grünewald, Thomas G. P.
Bini, Carla
Lollini, Pier-Luigi
Longhi, Alessandra
Donati, Davide Maria
Scotlandi, Katia
author_facet Pasello, Michela
Giudice, Anna Maria
Cristalli, Camilla
Manara, Maria Cristina
Mancarella, Caterina
Parra, Alessandro
Serra, Massimo
Magagnoli, Giovanna
Cidre-Aranaz, Florencia
Grünewald, Thomas G. P.
Bini, Carla
Lollini, Pier-Luigi
Longhi, Alessandra
Donati, Davide Maria
Scotlandi, Katia
author_sort Pasello, Michela
collection PubMed
description PURPOSE: The relevance of the subfamily A members of ATP-binding cassette (ABCA) transporters as biomarkers of risk and response is emerging in different tumors, but their mechanisms of action have only been partially defined. In this work, we investigated their role in Ewing sarcoma (EWS), a pediatric cancer with unmet clinical issues. METHODS: The expression of ABC members was evaluated by RT-qPCR in patients with localized EWS. The correlation with clinical outcome was established in different datasets using univariate and multivariate statistical methods. Functional studies were conducted in cell lines from patient-derived xenografts (PDXs) using gain- or loss-of-function approaches. The impact of intracellular cholesterol levels and cholesterol lowering drugs on malignant parameters was considered. RESULTS: We found that ABCA6, which is usually poorly expressed in EWS, when upregulated became a prognostic factor of a favorable outcome in patients. Mechanistically, high expression of ABCA6 impaired cell migration and increased cell chemosensitivity by diminishing the intracellular levels of cholesterol and by constitutive IGF1R/AKT/mTOR expression/activation. Accordingly, while exposure of cells to exogenous cholesterol increased AKT/mTOR activation, the cholesterol lowering drug simvastatin inhibited IGF1R/AKT/mTOR signaling and prevented Ser166 phosphorylation of MDM2. This, in turn, favored p53 activation and enhanced pro-apoptotic effects of doxorubicin. CONCLUSIONS: Our study reveals that ABCA6 acts as tumor suppressor in EWS cells via cholesterol-mediated inhibition of IGF1R/AKT/MDM2 signaling, which promotes the pro-apoptotic effects of doxorubicin and reduces cell migration. Our findings also support a role of ABCA6 as biomarker of EWS progression and sustains its assessment for a more rational use of statins as adjuvant drugs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13402-022-00713-5.
format Online
Article
Text
id pubmed-9747862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-97478622022-12-15 ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis Pasello, Michela Giudice, Anna Maria Cristalli, Camilla Manara, Maria Cristina Mancarella, Caterina Parra, Alessandro Serra, Massimo Magagnoli, Giovanna Cidre-Aranaz, Florencia Grünewald, Thomas G. P. Bini, Carla Lollini, Pier-Luigi Longhi, Alessandra Donati, Davide Maria Scotlandi, Katia Cell Oncol (Dordr) Original Article PURPOSE: The relevance of the subfamily A members of ATP-binding cassette (ABCA) transporters as biomarkers of risk and response is emerging in different tumors, but their mechanisms of action have only been partially defined. In this work, we investigated their role in Ewing sarcoma (EWS), a pediatric cancer with unmet clinical issues. METHODS: The expression of ABC members was evaluated by RT-qPCR in patients with localized EWS. The correlation with clinical outcome was established in different datasets using univariate and multivariate statistical methods. Functional studies were conducted in cell lines from patient-derived xenografts (PDXs) using gain- or loss-of-function approaches. The impact of intracellular cholesterol levels and cholesterol lowering drugs on malignant parameters was considered. RESULTS: We found that ABCA6, which is usually poorly expressed in EWS, when upregulated became a prognostic factor of a favorable outcome in patients. Mechanistically, high expression of ABCA6 impaired cell migration and increased cell chemosensitivity by diminishing the intracellular levels of cholesterol and by constitutive IGF1R/AKT/mTOR expression/activation. Accordingly, while exposure of cells to exogenous cholesterol increased AKT/mTOR activation, the cholesterol lowering drug simvastatin inhibited IGF1R/AKT/mTOR signaling and prevented Ser166 phosphorylation of MDM2. This, in turn, favored p53 activation and enhanced pro-apoptotic effects of doxorubicin. CONCLUSIONS: Our study reveals that ABCA6 acts as tumor suppressor in EWS cells via cholesterol-mediated inhibition of IGF1R/AKT/MDM2 signaling, which promotes the pro-apoptotic effects of doxorubicin and reduces cell migration. Our findings also support a role of ABCA6 as biomarker of EWS progression and sustains its assessment for a more rational use of statins as adjuvant drugs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13402-022-00713-5. Springer Netherlands 2022-09-23 2022 /pmc/articles/PMC9747862/ /pubmed/36149602 http://dx.doi.org/10.1007/s13402-022-00713-5 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Pasello, Michela
Giudice, Anna Maria
Cristalli, Camilla
Manara, Maria Cristina
Mancarella, Caterina
Parra, Alessandro
Serra, Massimo
Magagnoli, Giovanna
Cidre-Aranaz, Florencia
Grünewald, Thomas G. P.
Bini, Carla
Lollini, Pier-Luigi
Longhi, Alessandra
Donati, Davide Maria
Scotlandi, Katia
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
title ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
title_full ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
title_fullStr ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
title_full_unstemmed ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
title_short ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
title_sort abca6 affects the malignancy of ewing sarcoma cells via cholesterol-guided inhibition of the igf1r/akt/mdm2 axis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747862/
https://www.ncbi.nlm.nih.gov/pubmed/36149602
http://dx.doi.org/10.1007/s13402-022-00713-5
work_keys_str_mv AT pasellomichela abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT giudiceannamaria abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT cristallicamilla abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT manaramariacristina abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT mancarellacaterina abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT parraalessandro abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT serramassimo abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT magagnoligiovanna abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT cidrearanazflorencia abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT grunewaldthomasgp abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT binicarla abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT lollinipierluigi abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT longhialessandra abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT donatidavidemaria abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis
AT scotlandikatia abca6affectsthemalignancyofewingsarcomacellsviacholesterolguidedinhibitionoftheigf1raktmdm2axis